MX2009013646A - Metodos de diagnostico y tratamiento del cancer. - Google Patents

Metodos de diagnostico y tratamiento del cancer.

Info

Publication number
MX2009013646A
MX2009013646A MX2009013646A MX2009013646A MX2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A
Authority
MX
Mexico
Prior art keywords
methods
diagnosing
treating cancer
levels
rrm1
Prior art date
Application number
MX2009013646A
Other languages
English (en)
Spanish (es)
Inventor
Gerold Bepler
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Publication of MX2009013646A publication Critical patent/MX2009013646A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2009013646A 2007-06-15 2008-06-13 Metodos de diagnostico y tratamiento del cancer. MX2009013646A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94415707P 2007-06-15 2007-06-15
US3955508P 2008-03-26 2008-03-26
PCT/US2008/066918 WO2008157353A1 (en) 2007-06-15 2008-06-13 Methods of diagnosing and treating cancer

Publications (1)

Publication Number Publication Date
MX2009013646A true MX2009013646A (es) 2010-03-30

Family

ID=40156627

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013646A MX2009013646A (es) 2007-06-15 2008-06-13 Metodos de diagnostico y tratamiento del cancer.

Country Status (12)

Country Link
US (1) US20090017012A1 (enExample)
EP (1) EP2171086B1 (enExample)
JP (1) JP5479332B2 (enExample)
KR (1) KR20100044780A (enExample)
CN (1) CN101815793A (enExample)
AU (1) AU2008266048A1 (enExample)
BR (1) BRPI0813364A2 (enExample)
CA (1) CA2690865A1 (enExample)
ES (1) ES2401475T3 (enExample)
MX (1) MX2009013646A (enExample)
RU (1) RU2010101093A (enExample)
WO (1) WO2008157353A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080026093A (ko) * 2005-05-04 2008-03-24 유니버시티 오브 사우스 플로리다 암 환자의 치료 반응을 예측하는 방법
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN107254538A (zh) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
JP5024736B2 (ja) 2009-10-15 2012-09-12 住友電気工業株式会社 発電システム
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
RU2016119999A (ru) 2010-03-29 2018-11-08 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Способы лечения онкологических заболеваний
BR112012024590A2 (pt) 2010-03-29 2016-05-31 Abraxis Bioscience Inc métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
KR101602532B1 (ko) * 2013-08-29 2016-03-11 경북대학교 산학협력단 위암의 재발 가능성 예측을 위한 정보제공 방법
KR101949286B1 (ko) * 2015-10-26 2019-02-18 주식회사 싸이퍼롬 암 환자의 유전체 염기서열 변이 정보와 생존 정보를 이용한 맞춤형 약물 선택 방법 및 시스템
EP4178448A4 (en) * 2020-07-10 2025-06-18 Progenics Pharmaceuticals, Inc. Methods of making prostate cancer treatment decisions
CN113957145B (zh) * 2021-10-19 2023-09-26 中国医学科学院肿瘤医院 m6A相关lncRNA在预测小细胞肺癌预后和化疗反应的应用
CN114564622B (zh) * 2022-03-03 2025-07-25 苏州良医汇网络科技有限公司 一种tnm分期表录入系统的方法、装置以及设备

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705336A (en) * 1995-03-07 1998-01-06 The United States Of America As Represented By The Department Of Health And Human Services Assay for sensitivity of tumors to DNA-platinating chemotherapy
US20020090642A1 (en) * 1995-12-11 2002-07-11 Patrick G. Johnston Methods for determining the prognosis of breast cancer using antibodies specific for thymidylate synthase
US6416987B1 (en) * 1997-02-04 2002-07-09 Sloan Kettering Institute For Cancer Research Mutants of thymidylate synthase and uses thereof
US6087489A (en) * 1998-06-02 2000-07-11 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of human thymidylate synthase expression
WO2001000799A1 (en) * 1999-06-28 2001-01-04 Takeda Chemical Industries, Ltd. Novel protein and dna thereof
US6248535B1 (en) * 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
US6602670B2 (en) * 2000-12-01 2003-08-05 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
US6582919B2 (en) * 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US7049059B2 (en) * 2000-12-01 2006-05-23 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
US6518416B1 (en) * 2000-12-01 2003-02-11 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
US6956111B2 (en) * 2001-03-02 2005-10-18 Response Genetics, Inc. Method of determining dihydropyrimidine dehydrogenase gene expression
US6686155B2 (en) * 2001-06-14 2004-02-03 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
EP1546376B9 (en) * 2002-09-30 2009-08-12 F.Hoffmann-La Roche Ag Oligonucleotides for genotyping thymidylate synthase gene
JP2007507770A (ja) * 2003-09-29 2007-03-29 パスワーク インフォーマティクス，インコーポレーテッド 生物学的特徴を検出するためのシステムおよび方法
KR20080026093A (ko) * 2005-05-04 2008-03-24 유니버시티 오브 사우스 플로리다 암 환자의 치료 반응을 예측하는 방법

Also Published As

Publication number Publication date
RU2010101093A (ru) 2011-07-20
JP5479332B2 (ja) 2014-04-23
EP2171086B1 (en) 2012-12-19
ES2401475T3 (es) 2013-04-19
CA2690865A1 (en) 2008-12-24
US20090017012A1 (en) 2009-01-15
BRPI0813364A2 (pt) 2014-12-30
EP2171086A4 (en) 2010-10-13
WO2008157353A1 (en) 2008-12-24
JP2010530746A (ja) 2010-09-16
KR20100044780A (ko) 2010-04-30
AU2008266048A1 (en) 2008-12-24
EP2171086A1 (en) 2010-04-07
CN101815793A (zh) 2010-08-25

Similar Documents

Publication Publication Date Title
MX2009013646A (es) Metodos de diagnostico y tratamiento del cancer.
WO2019213282A8 (en) Biomarkers for evaluating car-t cells to predict clinical outcome
WO2006135886A3 (en) Compositions and methods for treating and diagnosing cancer
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
WO2008008500A3 (en) Methods for making cancer prognoses based on the subcellular localization of biomarkers
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
WO2010018601A3 (en) Genetic variants predictive of cancer risk
WO2007053648A3 (en) Compositions and methods for treating and diagnosing cancer
WO2008061213A3 (en) Genetic variations associated with tumors
WO2008036691A3 (en) Biomarkers for prostate cancer and methods using the same
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2008117314A3 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2007123772A3 (en) Genes involved in estrogen metabolism
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2008070301A3 (en) Predicting lung cancer survival using gene expression
WO2012138783A3 (en) Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
WO2004097052A3 (en) Methods for prognosis and treatment of solid tumors
WO2007034221A3 (en) Non small cell lung cancer therapy prognosis and target
WO2012074904A3 (en) Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
MX2013000502A (es) Metodos y kits para el diagnostico de cancer de prostata.
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
WO2008037700A3 (en) Methods for breast cancer prognosis
MX2009004382A (es) Variaciones geneticas asociadas con tumores.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal